Stock of Hong Kong Stock Exchange Surges | The concept of innovative drugs is strong again, driven by favorable policies and expectations of business development. Institutions believe that the current valuation of the sector is still attractive.

According to the Securities Times app, the concept of innovative drugs has strengthened once again. As of the time of publication, CSPC Pharmaceutical Group-B (02157.HK) rose by 11.15% to 5.68 Hong Kong dollars; Kangfang Biotech (09926.HK) rose by 9.92% to 138.5 Hong Kong dollars; Kangnuo Bio (02162.HK) rose by 8.7% to 54.35 Hong Kong dollars; BeiGene (06160) rose by 7.3% to 177.8 Hong Kong dollars; Sansee Pharmaceuticals (01530) rose by 6.08% to 29.65 Hong Kong dollars; Yasheng Pharmaceuticals-B (06855) rose by 5.08% to 77.6 Hong Kong dollars.